| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.035 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |